These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8658813)

  • 21. Hyperamylasemia in kidney transplant recipients.
    Yokoyama I; Hayashi S; Kobayashi T; Negita M; Katayama A; Nagasaka R; Namii Y; Kojima T; Koike C; Uchida K; Takagi H
    Transplant Proc; 1996 Jun; 28(3):1476-7. PubMed ID: 8658748
    [No Abstract]   [Full Text] [Related]  

  • 22. Chronic rejection in cyclosporin A treated renal allograft recipients with allopeptide reactive T cells.
    Iniotaki-Theodoraki A; Boletis J; Stamatiadis D; Choremi H; Kostakis A
    Transplant Proc; 1999; 31(1-2):1168-70. PubMed ID: 10083522
    [No Abstract]   [Full Text] [Related]  

  • 23. Flow cytometry crossmatch: a sensitive technique for assessment of acute rejection in renal transplantation.
    Piazza A; Adorno D; Poggi E; Borrelli L; Buonomo O; Pisani F; Valeri M; Torlone N; Camplone C; Monaco PI; Fraboni D; Casciani CU
    Transplant Proc; 1998 Aug; 30(5):1769-71. PubMed ID: 9723274
    [No Abstract]   [Full Text] [Related]  

  • 24. [Therapy of chronic hepatitis].
    Dioguardi N
    Minerva Med; 1974 Nov; 65(82):4261-6. PubMed ID: 4431580
    [No Abstract]   [Full Text] [Related]  

  • 25. The use of combined intravenous pulse methylprednisolone and low-dose oral cyclosporin A in the treatment of corneal graft rejection: addendum to previous report.
    Wong AK; Tham CC; Leung AT; Lam DS
    Eye (Lond); 1999 Aug; 13 ( Pt 4)():584-5. PubMed ID: 10692936
    [No Abstract]   [Full Text] [Related]  

  • 26. Kidney transplantations with HBsAg+ donors.
    Bedrossian J; Akposso K; Metivier F; Moal MC; Pruna A; Idatte JM
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1481-2. PubMed ID: 8442160
    [No Abstract]   [Full Text] [Related]  

  • 27. Low incidence of acute rejection in kidney grafts treated with initial quadruple therapy: a retrospective analysis comparing two ATGs.
    Civati G; Minetti E; Busnach G; Perego A; Brando B; Broggi ML; Sansalone V; Forti D
    Transplant Proc; 1998 Jun; 30(4):1343-5. PubMed ID: 9636546
    [No Abstract]   [Full Text] [Related]  

  • 28. Pre- versus intraoperative application of glucocorticosteroids as inductive therapy in renal transplantation.
    Fricke L; Leeker A; Kreft B; Klüter H; Hoyer J; Steinhoff J; Sack K
    Transplant Proc; 1998 Jun; 30(4):1346-7. PubMed ID: 9636547
    [No Abstract]   [Full Text] [Related]  

  • 29. Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients.
    Lorber MI; Flechner SM; Van Buren CT; Kerman RH; Kahan BD
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):282-5. PubMed ID: 3895668
    [No Abstract]   [Full Text] [Related]  

  • 30. Randomized trial to evaluate the use of increasing the steroid dose during conversion from cyclosporine to azathioprine.
    Roodnat JI; Zietse R; Rischen-Vos J; van Gelder T; IJzermans JN; Weimar W
    Transplant Proc; 1998 Jun; 30(4):1199-200. PubMed ID: 9636486
    [No Abstract]   [Full Text] [Related]  

  • 31. Does cyclosporine influence the outcome in patients with acute tubular necrosis after renal transplantation.
    Ritz M; Botha J; Pontin AR; Pascoe MD; Kahn D
    Transplant Proc; 1999; 31(1-2):303. PubMed ID: 10083117
    [No Abstract]   [Full Text] [Related]  

  • 32. Critical neurologic illness in the immunocompromised patient.
    Cohen JA; Raps EC
    Neurol Clin; 1995 Aug; 13(3):659-77. PubMed ID: 7476823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical study on application of bailing capsule after renal transplantation].
    Sun M; Yang YR; Lu YP; Gao R; Wang L; Wang J; Tang K
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2004 Sep; 24(9):808-10. PubMed ID: 15495826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of deoxyspergualin on acute and chronic rejection in renal transplantation.
    Nomura Y; Tomikawa S; Beck Y; Nishimura Y; Meigata K; Ando Y; Kikuchi K
    Transplant Proc; 1998 Nov; 30(7):3580-1. PubMed ID: 9838568
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunosuppression protocols for HLA identical renal transplant recipients.
    Keitel E; Santos AF; Alves MA; Neto JP; Schaefer PG; Bittar AE; Goldani JC; Pozza R; Bruno RM; See D; Garcia CD; Garcia VD
    Transplant Proc; 2003 May; 35(3):1074-5. PubMed ID: 12947863
    [No Abstract]   [Full Text] [Related]  

  • 36. Morbidity after renal transplantation: role of bacterial infection.
    García VD; Keitel E; Almeida P; Santos AF; Becker M; Goldani JC
    Transplant Proc; 1995 Apr; 27(2):1825-6. PubMed ID: 7725521
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of steroids amount on hepatitis C recurrence following orthtopic liver transplantation.
    Tisone G; Laria G; Orlando G; Pisani F; Palmieri GP; Bellanova G; Torri E; Buonomo O; Angelico M; Casciani CU
    Transplant Proc; 1999 Dec; 31(8):3167-8. PubMed ID: 10616427
    [No Abstract]   [Full Text] [Related]  

  • 38. Increased plasma LDL cholesterol after renal transplantation associated with cyclosporine immunosuppression.
    Raine AE; Carter R; Mann JI; Chapman JR; Morris PJ
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1820-1. PubMed ID: 3274428
    [No Abstract]   [Full Text] [Related]  

  • 39. A randomized trial of deflazacort versus 6-methylprednisolone in renal transplantation--immunosuppressive activity and side effects.
    Elli A; Rivolta R; Di Palo FQ; Parenti M; Vergallo G; Palazzi P; Zafiropulu S; Abelli P; Zanussi C
    Transplantation; 1993 Jan; 55(1):209-12. PubMed ID: 8420051
    [No Abstract]   [Full Text] [Related]  

  • 40. Protein catabolic rate after renal transplantation.
    Edelstein CL; van Zyl J; Moosa MR; Labadarios D
    Transplant Proc; 1992 Oct; 24(5):1775-6. PubMed ID: 1412838
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.